Chemed vs Hims & Hers Health
Chemed reported revenue of $2.5 billion in fiscal 2025, about the same as Hims & Hers Health's $2.3 billion in fiscal 2025. Chemed's revenue grew 4.1% in its latest year, and Hims & Hers Health's grew 59.0%. Chemed had an operating margin of 13.4%, against 4.5% at Hims & Hers Health. Free cash flow was $325 million at Chemed and $57 million at Hims & Hers Health.
Side by side
| Chemed | Hims & Hers Health | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $2.5B | $2.3B |
| Revenue growth | 4.1% | 59.0% |
| Revenue growth a year, last 5 years | 4.0% | 73.6% |
| Gross margin | 32.5% | 73.8% |
| Operating margin | 13.4% | 4.5% |
| Net margin | 10.5% | 5.5% |
| Free cash flow | $325M | $57M |
| Free cash flow margin | 12.9% | 2.5% |
| Return on capital | 27.3% | 19.0% |
| Net debt to EBITDA | −0.2x | 2.5x |
| Dividends and buybacks | $463M | $90M |
| Change in diluted share count | −4.8% | 9.1% |
| Last close | $512.90 | $27.59 |
| P/E at the last close | 25.8× | — |
| Insider trades, last 12 months | sold $8.8 million | bought $1.2 million, sold $19.3 million |
| Piotroski F-score | 5 of 9 | 4 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
ChemedHims & Hers Health
Operating margin
Percent of revenue
ChemedHims & Hers Health
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ChemedHims & Hers Health
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Chemed and Hims & Hers Health pages.